A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(44 sites)

United States

Research Site, Newport Beach, California

Research Site, Chicago, Illinois

Research Site, Chestnut Hill, Massachusetts

Research Site, Columbia, Missouri

Bulgaria

Research Site, Plovdiv